Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check6 days agoChange DetectedRecord history now shows Revision: v3.4.3 replacing the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe latest version entry is added to the record history, with the newest update timestamp and color-coded additions/deletions shown in the history list.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, and earlier notices such as the funding lapse message and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide funding-status notice and Revision: v3.4.1; removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe new version adds a glossary toggle, introduces color-coded highlights for additions and deletions, and updates the revision information.SummaryDifference0.5%

- Check62 days agoChange DetectedOn 2026-01-09, the record history shows updates to Contacts/Locations and Study Status. The update is associated with Revision: v3.3.4, with a prior Revision: v3.3.3 removed on 2025-09-30.SummaryDifference0.3%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.